EarningsQ3 2023 Earnings Report

Tandem Diabetes Care (TNDM) Q3 2023 Earnings Report

0 Followers

MX:TNDM Q3 2023 EPS Results

Actual EPS-$9.31

Consensus EPS-$8.78

Beat/MissMissed by -$0.53

One Year Ago EPS-$13.87

Actual Revenue$3.39B

Expected Revenue$3.52B

Beat/MissMissed by -$130.25M

YoY Revenue Growth-9.25%

QuarterQ3 2023

Date11/01/2023

TimeAfter Close

Conference CallWednesday, November 1, 2023

MX:TNDM Upcoming Earnings

Tandem Diabetes Care's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:TNDM Q3 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-4.47 / -	-5.714	―
Aug 06, 2026	2026 (Q2)	-5.86 / -5.60	-8.799	36.31% (+3.19)
May 07, 2026	2026 (Q1)	-8.10 / -5.44	-12.212	55.46% (+6.77)
Feb 19, 2026	2025 (Q4)	-1.70 / -0.16	0.183	-190.00% (-0.35)
Nov 06, 2025	2025 (Q3)	-6.01 / -5.71	-6.389	10.57% (+0.68)
Aug 06, 2025	2025 (Q2)	-7.28 / -8.80	-8.58	-2.55% (-0.22)
Apr 30, 2025	2025 (Q1)	-11.04 / -12.21	-11.865	-2.92% (-0.35)
Feb 26, 2025	2024 (Q4)	-3.72 / 0.18	-8.397	102.17% (+8.58)
Nov 06, 2024	2024 (Q3)	-7.36 / -6.39	-9.31	31.37% (+2.92)
Aug 01, 2024	2024 (Q2)	-9.77 / -8.58	-10.04	14.55% (+1.46)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed